If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Strategic Contract Win

19 Oct 2020 07:00

RNS Number : 3873C
PROACTIS Holdings PLC
19 October 2020
 

Proactis Holdings PLC

Strategic Contract Win

 

Proactis Holdings PLC, ("Proactis", the "Group" or the "Company"), the business spend management solution provider, is pleased to announce that it has signed a 7-year contract with Union Sanitaire et Sociale Aude Pyrénées ("USSAP") to provide its business spend management solution.

 

As announced previously, the Group adopted a new go-to market strategy for each of its US, France and Germany territories designed to replicate that of the UK and Netherlands. This contract win represents a strategically important milestone, being the first new customer in France to sign up under that new strategy.

 

The solution will cover the contract to order process and will initially be deployed with 100 users with an expectation to increase the number substantially during 2021.

 

USSAP is a not-for-profit organisation in the medical and health sector located in the South-West region of France consisting of 60 self-managed locations and approximately 1,700 employees.

Ms. Valliere, Chief Financial Officer at USSAP, commented:

"After a year and a half researching the market, USSAP selected Proactis because of its experience with major players in the healthcare sector such as UniHA and AP-HP. We particularly appreciated the ergonomy and intuitive use of the Proactis solution and, as a non-profit association, we also seek value. The ability to implement the Proactis solution quickly and without additional integration and training costs was crucial."

Tim Sykes, Chief Executive Officer at Proactis, commented:

"This contract win is a crucial proof point in Proactis' strategy to sell its single business spend management solution internationally. We are delighted to have been selected by USSAP in France following our success at DWIYDAG in Germany."

For further information, please contact:

Proactis Holdings PLC

Tim Sykes, Chief Executive Officer

 

01937 545070 investorcontact@proactis.com

finnCap Ltd

Carl Holmes/Emily Watts/Matthew Radley - Corporate Finance

Andrew Burdis/Richard Chambers - ECM

 

0207 220 0500

 

 

Alma PR

Rebecca Sanders-Hewett, Sam Modlin, David Ison

 

020 3405 0205

Proactis@almapr.co.uk

 

Notes to Editors:

Proactis creates, sells and maintains software and services which enable organisations to streamline, control and monitor all indirect expenditure. Its solutions are used in approximately 1,100 buying organisations around the world from the commercial, public and not-for-profit sectors.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKEKFEFEFFA
Date   Source Headline
22nd Jan 20187:00 amRNSIssue of Equity
18th Jan 20187:00 amRNSFiling of Tender Offer for Hubwoo
15th Jan 20187:00 amRNSIssue of Equity
5th Jan 201810:04 amRNSTR-1: Notification of major holdings
18th Dec 201710:40 amRNSResult of AGM
7th Dec 201710:06 amRNSIssue of Equity
5th Dec 20173:09 pmRNSHolding(s) in Company
30th Nov 20177:00 amRNSAnnual Report and Accounts & Notice of AGM
13th Nov 20177:00 amRNSDirector/PDMR Shareholding
10th Nov 20177:00 amRNSIssue of Equity
3rd Nov 20172:36 pmRNSHolding(s) in Company
13th Oct 20177:00 amRNSDirector/PDMR Shareholding
11th Oct 20177:00 amRNSFinal Results
5th Sep 201712:19 pmRNSIssue of Equity
29th Aug 20177:00 amRNSGrant of Options
22nd Aug 20177:00 amRNSTrading Update & Notice of Results
7th Aug 20177:00 amRNSCompletion of Acquisition and Re-admission
31st Jul 201712:00 pmRNSResult of General Meeting and Total Voting Rights
20th Jul 20177:00 amRNSHolding(s) in Company
10th Jul 20172:28 pmRNSHolding(s) in Company
10th Jul 201711:56 amRNSHolding(s) in Company
7th Jul 20178:00 amRNSSch 1 - Proactis Holdings Plc
7th Jul 20177:00 amRNSProposed Acquisition, Placing & Notice of GM
3rd May 20177:00 amRNSIssue of Equity and Total Voting Rights
26th Apr 20177:00 amRNSInterim Results
4th Apr 20177:00 amRNSHolding(s) in Company
3rd Apr 20176:19 pmRNSHolding(s) in Company
13th Mar 20177:00 amRNSIssue of Equity and Total Voting Rights
20th Feb 20177:00 amRNSTrading Statement
30th Jan 20177:00 amRNSDirector Shareholdings, Issue of Equity & TVR
19th Dec 201612:49 pmRNSResult of AGM
19th Dec 20167:00 amRNSDirectorate Change
29th Nov 20167:00 amRNSIssue of Equity
28th Nov 20162:47 pmRNSAnnual Report and Accounts & Notice of AGM
28th Nov 20162:40 pmRNSHolding(s) in Company
17th Nov 20167:00 amRNSCompletion of Acquisition
10th Nov 201611:36 amRNSResult of Placing
10th Nov 201611:05 amRNSSecond Price Monitoring Extn
10th Nov 201611:00 amRNSPrice Monitoring Extension
10th Nov 20167:00 amRNSProposed Acquisition and Placing
12th Oct 20167:00 amRNSPreliminary Results
9th Sep 20163:04 pmRNSHolding(s) in Company
7th Sep 20165:07 pmRNSHolding(s) in Company
19th Aug 201610:42 amRNSHolding(s) in Company
11th Aug 20167:00 amRNSTrading Update & Notice of Results
29th Jul 20167:00 amRNSDirector/PDMR Shareholding
21st Jul 20167:00 amRNSIssue of Equity
14th Jul 201612:42 pmRNSHolding(s) in Company
6th Jul 20167:00 amRNSIssue of Equity
20th Jun 20167:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.